[ad_1]
The American Society of Breast Surgeons (ASBrS) recommends new badessments for bad cancer screening based on a formal risk badessment for all women over the age of 25, returning to age traditional screening for women at medium risk; and earlier annual screening for those at higher risk of contracting the disease.
The new guidelines, which differ from the American Preventive Services Task Force (USPSTF) and American Cancer Society (ACS) screening guidelines, were announced Friday at the group's annual meeting in Dallas.
"Starting the screening mammogram at age 40 probably saves more lives through early detection of the disease compared to alternative regimens, and so was the" traditional "age recommended in clinical practice until it About 10 years ago, when the USPSTF issued a revised directive, "Lisa Newman, MD, MPH, head of bad surgery at New York-Presbyterian medicine / Weill Cornell in New York, has MedPage today.
For medium-risk women, the USPSTF and ACS guidelines currently advocate routine screening at ages 50 and 45, respectively. These groups reported damage badociated with false positive screening results: unnecessary anxiety, overdiagnosis, pain, and risk of complications from follow-up biopsies. The vast majority of positive results obtained with screening mammography are false, according to an article cited by the authors of the guideline.
The ASBrS statement also acknowledged the "known drawbacks" of mammography among 40- to 49-year-olds and said that women "should be informed of the potential drawbacks".
Nevertheless, "the ASBrS position statement advocates an annual screening mammogram starting at age 40, as we have chosen to prioritize the benefits of screening mammography that save lives," he said. Newman, committee member who developed the ASBrS guidelines. "In addition, as physicians who guide patients every day in the management of bad cancer care, we have unique insights into the value of early detection and its impact. on surgical, systemic and radiotherapeutic options. "
ASBrS position
In all scenarios, tomosynthesis (or 3D mammography) is the preferred option for mammography screening, according to instructions developed by an ASBrS panel and co-chaired by Shawna Willey, MD, of Medstar Hospital. Georgetown University, Washington, and Pat Whitworth. , MD, of the Nashville Breast Center in Tennessee.
For medium-risk women, the ASBrS guide asks all women to have an annual mammogram beginning at age 40, and recommends that additional imaging be considered for women with higher bad density (C and D). heterogeneous or extremely dense).
For women with a higher risk of bad cancer due to hereditary predisposition genes or anterior chest wall irradiation, ASBrS recommends annual MRI from 25 years of age and annual mammogram to from 30 years old.
For women at higher risk because of a strong family history or whose estimated lifetime risk is greater than 20% according to the Claus, BRCAPRO or Tyrer-Cuzick risk badessment models, the company recommends annual mammography at from age 35 and access to additional imaging when recommended by their physician (preferably MRI).
"At the present time, we have the most reliable data on bad cancer risk and the benefits of screening for women with pathogenic mutations. BRCA1 and BRCA2 Newman, said: "History of therapeutic radiation in the chest wall in adolescence / early adulthood and in women with a strong family history of early bad cancer (even if no mutation pathogen has been identified in the family) constitute other examples of mammographic screening at younger ages, as well as complementary screening by bad MRI, should be considered. "
For women 50 years and older with a history of bad cancer, the ASBrS position statement provides for an annual mammogram. For women with a history of cancer and who are under 50 years of age or who have dense bads, the group requires annual mammography and access to additional imaging on the recommendation of their physician (preferably by MRI).
Women whose life expectancy is less than 10 years old should no longer be screened for bad cancer, according to ASBrS.
Newman noted that the group's position is unique because of the special importance given to mammography screening as a way to address disparities in bad cancer.
"African-American women have younger bad cancer than white Americans and are more likely to be diagnosed with the biologically-negative phenotype biologically aggressive at all ages," she said. "These trends undoubtedly contribute to the increase in bad cancer mortality rates among African-American women.The ASBrS mammography screening recommendation is clear, evidence-based and offers an opportunity to reduce disparities in bad cancer. bad badociated with race / ethnicity by improving early detection among all women ".
2019-05-03T17: 30: 00-0400
Source link
